ACRX insider filings

ACELRX PHARMACEUTICALS INC — 50 most recent insider filings (SEC Forms 3/4/5) from EDGAR, normalized by FilingPulse. Latest filing: 2023-12-14. Screen ACRX transaction legs live →

Insider transaction summary — last 90 days

No insider filings (Forms 3/4/5) for ACRX between 2026-08-23 and 2026-11-21. The table below lists the most recent filings on record.

Recent insider filings — ACELRX PHARMACEUTICALS INC

FiledFormInsiderReported transactionsSource
2023-12-144Angotti Vincent J. — Chief Executive Officer, DirectorPurchase (P): 10,000 @ $0.73EDGAR
2023-12-134Afable Richard — DirectorGrant/award (A): 581 @ $0 · Grant/award (A): 3,487 (derivative) @ $0EDGAR
2023-12-134Bozilenko Marina — DirectorGrant/award (A): 581 @ $0 · Grant/award (A): 3,487 (derivative) @ $0EDGAR
2023-12-134Rosen Howard B — DirectorGrant/award (A): 581 @ $0 · Grant/award (A): 3,487 (derivative) @ $0EDGAR
2023-12-134ADAMS ADRIAN — DirectorGrant/award (A): 581 @ $0 · Grant/award (A): 3,487 (derivative) @ $0EDGAR
2023-12-134Broadfoot Jill Marie — DirectorGrant/award (A): 581 @ $0 · Grant/award (A): 3,487 (derivative) @ $0EDGAR
2023-12-134WAN MARK A — DirectorGrant/award (A): 581 @ $0 · Grant/award (A): 3,487 (derivative) @ $0EDGAR
2023-12-134HOFFMAN STEPHEN J — DirectorGrant/award (A): 581 @ $0 · Grant/award (A): 3,487 (derivative) @ $0EDGAR
2023-09-114Angotti Vincent J. — Chief Executive Officer, DirectorPurchase (P): 10,000 @ $0.80EDGAR
2023-08-254Palmer Pamela P — Chief Medical Officer, DirectorSale (S): 9,514 @ $1.17 · Sale (S): 7,442 @ $1.09EDGAR
2023-03-064Palmer Pamela P — Chief Medical Officer, DirectorTax withholding (F): 570 @ $1.31EDGAR
2023-03-064ASADORIAN RAFFI — Chief Financial OfficerTax withholding (F): 510 @ $1.31EDGAR
2023-03-064Angotti Vincent J. — Chief Executive Officer, DirectorTax withholding (F): 1,703 @ $1.31EDGAR
2023-03-064Dasu Badri N — Chief Engineering OfficerTax withholding (F): 398 @ $1.31EDGAR
2023-02-144Palmer Pamela P — Chief Medical Officer, DirectorGrant/award (A): 6,125 @ $0 · Tax withholding (F): 1,017 @ $1.68 · Grant/award (A): 36,750 (derivative) @ $0EDGAR
2023-02-144ASADORIAN RAFFI — Chief Financial OfficerGrant/award (A): 5,875 @ $0 · Tax withholding (F): 873 @ $1.68 · Grant/award (A): 35,250 (derivative) @ $0EDGAR
2023-02-144Angotti Vincent J. — Chief Executive Officer, DirectorGrant/award (A): 19,500 @ $0 · Tax withholding (F): 3,321 @ $1.68 · Grant/award (A): 117,000 (derivative) @ $0EDGAR
2023-02-144Dasu Badri N — Chief Engineering OfficerGrant/award (A): 4,875 @ $0 · Tax withholding (F): 776 @ $1.68 · Grant/award (A): 29,250 (derivative) @ $0EDGAR
2023-02-084ASADORIAN RAFFI — Chief Financial OfficerTax withholding (F): 617 @ $2.02EDGAR
2023-02-084Palmer Pamela P — Chief Medical Officer, DirectorTax withholding (F): 681 @ $2.02EDGAR
2023-02-084Angotti Vincent J. — Chief Executive Officer, DirectorTax withholding (F): 1,982 @ $2.02EDGAR
2023-02-084Dasu Badri N — Chief Engineering OfficerTax withholding (F): 458 @ $2.02EDGAR
2022-07-154Bozilenko Marina — DirectorGrant/award (A): 15,500 @ $0 · Grant/award (A): 31,000 (derivative) @ $0EDGAR
2022-07-154Afable Richard — DirectorGrant/award (A): 15,500 @ $0 · Grant/award (A): 31,000 (derivative) @ $0EDGAR
2022-07-154Rosen Howard B — DirectorGrant/award (A): 15,500 @ $0 · Grant/award (A): 31,000 (derivative) @ $0EDGAR
2022-07-154Broadfoot Jill Marie — DirectorGrant/award (A): 15,500 @ $0 · Grant/award (A): 31,000 (derivative) @ $0EDGAR
2022-07-154ADAMS ADRIAN — DirectorGrant/award (A): 15,500 @ $0 · Grant/award (A): 31,000 (derivative) @ $0EDGAR
2022-07-154WAN MARK A — DirectorGrant/award (A): 15,500 @ $0 · Grant/award (A): 31,000 (derivative) @ $0EDGAR
2022-07-154HOFFMAN STEPHEN J — DirectorGrant/award (A): 15,500 @ $0 · Grant/award (A): 31,000 (derivative) @ $0EDGAR
2022-06-084Angotti Vincent J. — Chief Executive Officer, DirectorPurchase (P): 46,400 @ $0.22EDGAR
2022-03-044Palmer Pamela P — Chief Medical Officer, DirectorTax withholding (F): 7,923 @ $0.41EDGAR
2022-03-044ASADORIAN RAFFI — Chief Financial OfficerTax withholding (F): 7,923 @ $0.41EDGAR
2022-03-044Angotti Vincent J. — Chief Executive Officer, DirectorTax withholding (F): 23,051 @ $0.41EDGAR
2022-03-044Dasu Badri N — Chief Engineering OfficerTax withholding (F): 5,612 @ $0.41EDGAR
2022-02-144Palmer Pamela P — Chief Medical Officer, DirectorGrant/award (A): 122,500 @ $0 · Tax withholding (F): 7,927 @ $0.40 · Grant/award (A): 245,000 (derivative) @ $0EDGAR
2022-02-144ASADORIAN RAFFI — Chief Financial OfficerGrant/award (A): 117,500 @ $0 · Tax withholding (F): 7,927 @ $0.40 · Grant/award (A): 235,000 (derivative) @ $0EDGAR
2022-02-144Angotti Vincent J. — Chief Executive Officer, DirectorGrant/award (A): 390,000 @ $0 · Tax withholding (F): 23,058 @ $0.40 · Grant/award (A): 780,000 (derivative) @ $0EDGAR
2022-02-144Dasu Badri N — Chief Engineering OfficerGrant/award (A): 97,500 @ $0 · Tax withholding (F): 5,615 @ $0.40 · Grant/award (A): 195,000 (derivative) @ $0EDGAR
2022-02-074Palmer Pamela P — Chief Medical Officer, DirectorTax withholding (F): 9,391 @ $0.43EDGAR
2022-02-074ASADORIAN RAFFI — Chief Financial OfficerTax withholding (F): 9,391 @ $0.43EDGAR
2022-02-074Angotti Vincent J. — Chief Executive Officer, DirectorTax withholding (F): 27,318 @ $0.43EDGAR
2022-02-074Dasu Badri N — Chief Engineering OfficerTax withholding (F): 6,830 @ $0.43EDGAR
2021-11-234Broadfoot Jill Marie — DirectorGrant/award (A): 15,000 @ $0 · Grant/award (A): 30,000 (derivative) @ $0EDGAR
2021-06-174Afable Richard — DirectorGrant/award (A): 10,000 @ $0 · Grant/award (A): 20,000 (derivative) @ $0EDGAR
2021-06-174Bozilenko Marina — DirectorGrant/award (A): 10,000 @ $0 · Grant/award (A): 20,000 (derivative) @ $0EDGAR
2021-06-174Rosen Howard B — DirectorGrant/award (A): 10,000 @ $0 · Grant/award (A): 20,000 (derivative) @ $0EDGAR
2021-06-174ADAMS ADRIAN — DirectorGrant/award (A): 10,000 @ $0 · Grant/award (A): 20,000 (derivative) @ $0EDGAR
2021-06-174WAN MARK A — DirectorGrant/award (A): 10,000 @ $0 · Grant/award (A): 20,000 (derivative) @ $0EDGAR
2021-06-174EDWARDS MARK G — DirectorGrant/award (A): 10,000 @ $0 · Grant/award (A): 20,000 (derivative) @ $0EDGAR
2021-06-174HOFFMAN STEPHEN J — DirectorGrant/award (A): 10,000 @ $0 · Grant/award (A): 20,000 (derivative) @ $0EDGAR

Recent 8-K events — ACELRX PHARMACEUTICALS INC

Items classified from EDGAR index headers. Browse recent 8-K filings market-wide, by item code →

FiledFormItems reportedSource
2026-11-128-K2.02 — Results of Operations and Financial Condition
9.01 — Financial Statements and Exhibits
EDGAR
2026-08-128-K2.02 — Results of Operations and Financial Condition
9.01 — Financial Statements and Exhibits
EDGAR
2026-06-238-K5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
5.07 — Submission of Matters to a Vote of Security Holders
9.01 — Financial Statements and Exhibits
EDGAR
2026-05-138-K2.02 — Results of Operations and Financial Condition
9.01 — Financial Statements and Exhibits
EDGAR
2026-03-238-K2.02 — Results of Operations and Financial Condition
9.01 — Financial Statements and Exhibits
EDGAR
2026-03-168-K3.02 — Unregistered Sales of Equity SecuritiesEDGAR
2026-03-138-K3.01 — Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of ListingEDGAR
2025-11-128-K2.02 — Results of Operations and Financial Condition
9.01 — Financial Statements and Exhibits
EDGAR
2025-10-248-K5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
5.07 — Submission of Matters to a Vote of Security Holders
9.01 — Financial Statements and Exhibits
EDGAR
2025-10-228-K3.02 — Unregistered Sales of Equity Securities
8.01 — Other Events
EDGAR
Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?ticker=ACRX returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. Get a free API key → · API docs